Stockreport

Plus Therapeutics Announces Share Repurchase Program

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF AUSTIN, Texas, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative, targeted radiot [Read more]